Ananda Developments Plc engages in the provision of cannabinoid medicines for the treatment of complex, chronic inflammatory pain conditions. The company was founded on January 19, 2018, and is headquartered in London, the United Kingdom.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company